 | anti-miR-145 | Artifically engineered RNA | miR-145 | TRAF6 | Homo sapiens (human) | 5Q-Syndrome Phenotype | 19898489 |
| anti-miR-145 | Artifically engineered RNA | miR-145 | TRAF6 | Mus musculus (mouse) | 5Q-Syndrome Phenotype | 19898489 |
| anti-miR-146a | Artifically engineered RNA | miR-146a | TRAF6 | Homo sapiens (human) | 5Q-Syndrome Phenotype | 19898489 |
| anti-miR-146a | Artifically engineered RNA | miR-146a | TRAF6 | Mus musculus (mouse) | 5Q-Syndrome Phenotype | 19898489 |
| HCG18 | LncRNA | miR-146a | TRAF6 | Homo sapiens (human) | Diabetic Peripheral Neuropathy | 32996080 |
| LOXL1-AS1 | LncRNA | miR-589-5p | TRAF6 | Homo sapiens (human) | Laryngocarcinoma | 33061856 |
| MALAT1 | LncRNA | miR-146b-5p | TRAF6 | Homo sapiens (human) | Hepatocellular Carcinoma | 28404923 |
| NEAT1 | LncRNA | miR-146b | TRAF6 | Homo sapiens (human) | Lupus Nephritis | 32710276 |
| PVT1 | LncRNA | miR-146a | TRAF6 | Homo sapiens (human) | Transplant Rejection | 34214903 |